loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Brincidofovir

    Client Email Product
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Brincidofovir

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Emergent BioSolutions Executes Contract Options For TEMBEXA
    Emergent BioSolutions Executes Contract Options For TEMBEXA

    26 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/26/2953776/33240/en/Emergent-BioSolutions-Announces-the-Execution-of-Contract-Options-Valued-at-67-4-Million-to-Procure-Additional-TEMBEXA-brincidofovir-to-Support-National-Preparedness-Efforts.html

    GLOBENEWSWIRE
    26 Sep 2024
    Share Share
    Emergent closes on buying smallpox drug Tembexa from Chimerix
    Emergent closes on buying smallpox drug Tembexa from Chimerix

    28 Sep 2022

    // Tyler Patchen ENDPTS

    https://endpts.com/emergent-closes-on-buying-smallpox-drug-tembexa-from-chimerix-with-a-238m-payment/

    Tyler Patchen ENDPTS
    28 Sep 2022
    Share Share
    Emergent acquires global rights for oral smallpox antiviral from Chimerix
    Emergent acquires global rights for oral smallpox antiviral from Chimerix

    27 Sep 2022

    // PHARMACEUTICAL-TECHNOLOGY

    https://www.pharmaceutical-technology.com/news/emergent-smallpox-antiviral/

    PHARMACEUTICAL-TECHNOLOGY
    27 Sep 2022
    Share Share
    Chimerix Announces TEMBEXA Procurement Agreement for Approximately $25.3M
    Chimerix Announces TEMBEXA Procurement Agreement for Approximately $25.3M

    24 Jun 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/06/24/2468864/25619/en/Chimerix-Announces-TEMBEXA-Procurement-Agreement-for-Approximately-25-3-Million-with-Public-Health-Agency-of-Canada.html

    GLOBENEWSWIRE
    24 Jun 2022
    Share Share
    Emergent adds another arrow to its medical ountermeasures quiver
    Emergent adds another arrow to its medical ountermeasures quiver

    16 May 2022

    // Fraiser Kansteiner FIERCEPHARMA

    https://www.fiercepharma.com/pharma/emergent-beefs-countermeasure-repertoire-325m-deal-chimerixs-smallpox-newcomer-tembexa

    Fraiser Kansteiner FIERCEPHARMA
    16 May 2022
    Share Share
    Emergent BioSolutions to Acquire from Chimerix, Exclusive WW Rights to TEMBEXA
    Emergent BioSolutions to Acquire from Chimerix, Exclusive WW Rights to TEMBEXA

    16 May 2022

    // PRESS RELEASE

    https://investors.emergentbiosolutions.com/news-releases/news-release-details/emergent-biosolutions-acquire-chimerix-its-exclusive-worldwide

    PRESS RELEASE
    16 May 2022
    Share Share